The Monash Institute of Cognitive and Clinical Neurosciences (MICCN) will explore and investigate untreated brain disorders, including ADHD, brain injury, memory loss and drug addiction.
Based at Monash University, the institute recently received the largest single philanthropic donation ever provided to the University, as evidence of the importance of the new Institute. The gift from the David Winston Turner Endowment Trust, valued at $5.25 million, will support ongoing research into the area of addiction.
MICCN will focus on four key areas that are critical to the wellbeing of Australians yet are having a greater impact on the health (and health budget) of the nation:
- Addiction – to drugs, gambling, alcohol and OCD
- Attention – such as in children with learning difficulties such as Autism
- Memory – such as age related changes in memory, and recovery from brain injury such as stroke
- Sleep – such as sleep related occupation risk (drowsy driving/shift work), insomnia etc
According to Director, Professor Kim Cornish, the MICCN will combine cutting edge research with experts from a broad range of disciplines and faculties as well as working with clinical and industry partners.
Monash University is ranked in the Top 100 Universities in the world, and has a number of world-class medical research institutes including MICCN, the Centre for Cancer Research and the Cardiovascular Research Centre.
Distinguished businessman and social entrepreneur Simon McKeon AO has recently been appointed by Monash University Council as the new Chancellor of Monash University.
Melbourne is a global medical research and development hub. Victoria is Australia's undisputed leader in medical research, annually receiving over 40 per cent of national government medical research funding.
Melbourne's medical research institutes have major programs covering cancer, inflammatory disorders, cardiovascular disease, diabetes, infectious disease, public health, neurological disorders and mental health. They also have expertise in medical bionics, eye diseases, stem cell science and paediatric research. Victoria also offers world-leading expertise and a highly favourable environment for clinical trials.